Cargando…
In Silico Screening of Natural Compounds for Candidates 5HT6 Receptor Antagonists against Alzheimer’s Disease
Alzheimer’s disease (AD), a devastating neurodegenerative disease, is the focus of pharmacological research. One of the targets that attract the most attention for the potential therapy of AD is the serotonin 5HT6 receptor, which is the receptor situated exclusively in CNS on glutamatergic and GABAe...
Autores principales: | Bojić, Tijana, Sencanski, Milan, Perovic, Vladimir, Milicevic, Jelena, Glisic, Sanja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101541/ https://www.ncbi.nlm.nih.gov/pubmed/35565976 http://dx.doi.org/10.3390/molecules27092626 |
Ejemplares similares
-
Identification of Candidate Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor Which May Improve Vagus Nerve Stimulation in Chronic Tinnitus
por: Bojić, Tijana, et al.
Publicado: (2017) -
In silico Therapeutics for Neurogenic Hypertension and Vasovagal Syncope
por: Bojić, Tijana, et al.
Publicado: (2016) -
Common molecular mechanism of the hepatic lesion and the cardiac parasympathetic regulation in chronic hepatitis C infection: a critical role for the muscarinic receptor type 3
por: Glišić, Sanja, et al.
Publicado: (2016) -
In Silico and In Vitro Inhibition of SARS-CoV-2 PL(pro) with Gramicidin D
por: Protić, Sara, et al.
Publicado: (2023) -
Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel In Silico Method
por: Sencanski, Milan, et al.
Publicado: (2020)